HOPE trial: hemodynamic optimization of cerebral perfusion after successful EVT in AIS

Pol Camps-Renom, MD, PhD, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, discusses the results of HOPE (NCT04892511), a randomized trial on hemodynamic optimization of cerebral perfusion after successful endovascular therapy (EVT) in patients with acute ischemic stroke (AIS). Dr Camps-Renom highlights that the trial found a significant improvement in functional outcomes at 90 days, meeting its primary endpoint. This interview took place at the 12th European Stroke Organisation Conference (ESOC) in Maastricht, The Netherlands. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.